What the business is, and whether it's a good one at a fair price.
Operates a chain of eye-care hospitals and primary clinics across India, with FY26 revenue from operations of INR 2,080 crores. Surgical services contributed 67% of group revenue, with the balance from primary clinics and consultations. In FY26 the network performed 3,23,000+ surgeries (up 14.5% YoY), including 62,800 cataract procedures, of which 5,900+ were robotic Femto Cataract surgeries. Patient payor mix stood at 62.4% cash, 28.5% insurance/TPA and 9% government schemes. Employee costs of 19.4% of revenue are the largest named operating cost, alongside other operating expenses of 43.9% and depreciation at 13.3% of revenue. The business is in an expansion phase, having commissioned 19 greenfield facilities in Q4 FY26 and guiding to 60 more in FY27 (40 surgical centres and 20 clinics) with planned capex of INR 380-400 crores.
Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from DR AGARWALS HEALTH CARE L's filed financials and exchange disclosures
DR AGARWALS HEALTH CARE L is a Healthcare Services company listed on NSE and BSE, trading under the symbol AGARWALEYE.
Yes. Over the trailing twelve months DR AGARWALS HEALTH CARE L reported a net profit of ₹185 Cr on revenue of ₹2,207 Cr.
Yes. The dividend yield is 0.01% at the current price. It paid out 1% of its profit as dividend in FY26.
No. Debt stands at 0.07× equity, and it carries net debt of ₹67 Cr. That is lower than 74% of its 24 Hospital peers.
On trailing P/E, DR AGARWALS HEALTH CARE L ranks 26 of 30 in Hospital — cheaper than 14% of them, against an industry median of 47.3×. This is a position, not a valuation judgement.
On a typical session DR AGARWALS HEALTH CARE L moves 0.98% — that is the median absolute close-to-close move across its last 269 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by DR AGARWALS HEALTH CARE L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
